535MO BGB-A333, an anti-PD-L1 monoclonal antibody, in combination with tislelizumab in patients with urothelial carcinoma
| Autor: | Liberal, J. Martin, Fong, P.C., Moreno, V., Frentzas, S., Desai, J., Meniawy, T., Markman, B., Voskoboynik, M., Budha, N., Wu, J., Shen, W., Singh, M., Calvo, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S468-S469 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|